文献
J-GLOBAL ID:202002217247633577
整理番号:20A2201673
SFPQ枯渇は,大腸癌細胞においてBRAF→γV600Eと合成的に致死性である【JST・京大機械翻訳】
SFPQ Depletion Is Synthetically Lethal with BRAFV600E in Colorectal Cancer Cells
著者 (38件):
Klotz-Noack Kathleen
(Charite - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health. Laboratory of Molecular Tumor Pathology and Systems Biology, Institute of Pathology, 10117 Berlin, Germany)
,
Klotz-Noack Kathleen
(German Cancer Consortium (DKTK), Partner Site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Klinger Bertram
(Charite - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health. Laboratory of Molecular Tumor Pathology and Systems Biology, Institute of Pathology, 10117 Berlin, Germany)
,
Klinger Bertram
(IRI Life Sciences & Institute of Theoretical Biology, Humboldt-Universitaet zu Berlin, 10115 Berlin, Germany)
,
Rivera Maria
(EPO Experimentelle Pharmakologie und Onkologie Berlin-Buch GmbH, Robert-Rossle-Str. 10, 13125 Berlin, Germany)
,
Bublitz Natalie
(Charite - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health. Laboratory of Molecular Tumor Pathology and Systems Biology, Institute of Pathology, 10117 Berlin, Germany)
,
Bublitz Natalie
(German Cancer Consortium (DKTK), Partner Site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Uhlitz Florian
(Charite - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health. Laboratory of Molecular Tumor Pathology and Systems Biology, Institute of Pathology, 10117 Berlin, Germany)
,
Uhlitz Florian
(IRI Life Sciences & Institute of Theoretical Biology, Humboldt-Universitaet zu Berlin, 10115 Berlin, Germany)
,
Riemer Pamela
(Charite - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health. Laboratory of Molecular Tumor Pathology and Systems Biology, Institute of Pathology, 10117 Berlin, Germany)
,
Luethen Mareen
(Charite - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health. Laboratory of Molecular Tumor Pathology and Systems Biology, Institute of Pathology, 10117 Berlin, Germany)
,
Luethen Mareen
(German Cancer Consortium (DKTK), Partner Site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Sell Thomas
(Charite - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health. Laboratory of Molecular Tumor Pathology and Systems Biology, Institute of Pathology, 10117 Berlin, Germany)
,
Sell Thomas
(IRI Life Sciences & Institute of Theoretical Biology, Humboldt-Universitaet zu Berlin, 10115 Berlin, Germany)
,
Kasack Katharina
(Charite - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health. Laboratory of Molecular Tumor Pathology and Systems Biology, Institute of Pathology, 10117 Berlin, Germany)
,
Kasack Katharina
(German Cancer Consortium (DKTK), Partner Site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Gastl Bastian
(Charite - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health. Laboratory of Molecular Tumor Pathology and Systems Biology, Institute of Pathology, 10117 Berlin, Germany)
,
Ispasanie Sylvia S.S.
(Charite - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health. Laboratory of Molecular Tumor Pathology and Systems Biology, Institute of Pathology, 10117 Berlin, Germany)
,
Simon Tincy
(Charite - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health. Laboratory of Molecular Tumor Pathology and Systems Biology, Institute of Pathology, 10117 Berlin, Germany)
,
Janssen Nicole
(Dr. Margarete Fischer-Bosch - Institute of Clinical Pharmacology, Auerbachstrasse 112, 70376 Stuttgart, Germany)
,
Janssen Nicole
(University of Tuebingen, 72074 Tuebingen, Germany)
,
Schwab Matthias
(Dr. Margarete Fischer-Bosch - Institute of Clinical Pharmacology, Auerbachstrasse 112, 70376 Stuttgart, Germany)
,
Schwab Matthias
(Departments of Clinical Pharmacology, Pharmacy and Biochemistry, University of Tuebingen, Auf der Morgenstelle 8, 72074 Tuebingen, Germany)
,
Schwab Matthias
(German Cancer Consortium (DKTK), Partner Site Tuebingen and German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Zuber Johannes
(Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), 1030 Vienna, Austria)
,
Zuber Johannes
(Medical University of Vienna, VBC, 1030 Vienna, Austria)
,
Horst David
(Charite - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health. Laboratory of Molecular Tumor Pathology and Systems Biology, Institute of Pathology, 10117 Berlin, Germany)
,
Horst David
(German Cancer Consortium (DKTK), Partner Site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Bluethgen Nils
(Charite - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health. Laboratory of Molecular Tumor Pathology and Systems Biology, Institute of Pathology, 10117 Berlin, Germany)
,
Bluethgen Nils
(IRI Life Sciences & Institute of Theoretical Biology, Humboldt-Universitaet zu Berlin, 10115 Berlin, Germany)
,
Bluethgen Nils
(German Cancer Consortium (DKTK), Partner Site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Schaefer Reinhold
(Charite - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health. Laboratory of Molecular Tumor Pathology and Systems Biology, Institute of Pathology, 10117 Berlin, Germany)
,
Schaefer Reinhold
(German Cancer Consortium (DKTK), Partner Site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Schaefer Reinhold
(Charite Comprehensive Cancer Center, Charite - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Chariteplatz 1, 10117 Berlin, Germany)
,
Morkel Markus
(Charite - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health. Laboratory of Molecular Tumor Pathology and Systems Biology, Institute of Pathology, 10117 Berlin, Germany)
,
Morkel Markus
(German Cancer Consortium (DKTK), Partner Site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Sers Christine
(Charite - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health. Laboratory of Molecular Tumor Pathology and Systems Biology, Institute of Pathology, 10117 Berlin, Germany)
,
Sers Christine
(German Cancer Consortium (DKTK), Partner Site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany)
資料名:
Cell Reports
(Cell Reports)
巻:
32
号:
12
ページ:
Null
発行年:
2020年
JST資料番号:
W3124A
ISSN:
2211-1247
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)